Table 3.
Preparation | Doses available | Starting dose of puberty | Increase approximately every 6 months* to adult dosing | Considerations for use |
---|---|---|---|---|
E2: transdermal options TD (some brands examples) | 3–7 µg/day | 25–100 µg/day | See text on applying patches | |
Menostar | 14 µg | Part of patch twice weekly | Only used for low dosing situations, not fully hypogonadal replacement | The easiest way to give a low dose |
Vivelle Dot | 25, 37.5, 50, 75, 100 µg | Part of patch twice weekly or 1 patch per month (no patch for 3 weeks)** | 25–100 µg twice weekly | Designed for twice weekly but can be given once per week to increase the dose slower |
Vivelle Mini | 25, 37.5, 50, 75, 100 µg | Part of patch twice weekly or 1 patch per month (no patch for 3 weeks)** | 25–100 µg twice weekly | Smaller size patch, but not smaller dosing |
Generic (different brands in different countries; e.g. Oesclim Estradot, Evorel, Systen, Climara, Demestril) | 25, 37.5, 50, 75, 100 µg | Part of patch twice weekly or 1 patch per month (no patch for 3 weeks)** | 25–100 µg twice weekly | Estradot: too small to properly cut into low doses and not stable in elevated temperature |
Estraderm | 25, 50, 100 µg | Part of patch twice weekly or 1 patch per month (no patch for 3 weeks)** | 25–100 µg twice weekly | Reservoir form cannot be used to initiate puberty |
Estraderm MX | ||||
Divigel 0.1% | 0.5 and 1.0 mg E2/sachet | Too potent for pubertal initiation | 1–2 sachets daily | Cannot use to initiate puberty |
Estragel 0.06% | 0.75 mg E2/pump | Too potent for pubertal initiation | 1–3 pumps daily | Cannot use to initiate puberty |
E2: oral options | 5 µg/kg/day | |||
17β-oestradiol (e.g.: Estrace, Cetura; Zumenon, Ormone, Estrofem mite, Estrofem) | 0.5, 1, 2, 4 mg | Part of a pill daily*** | 1–4 mg/day | The cheapest option, brands vary by country |
Oestradiol valerate (e.g. Climaval, Progynova) | ||||
Ethinyloestradiol (EE2) | 2 µg/day | 10–20 µg/day | Not available in many countries | |
Premarin (CEE) | 0.3, 0.625, 0.9, 1.25 mg | Part of pill daily | 0.625–1.25 mg/day | Not available in many countries |
Depot options | ||||
Depot E2 (cypionate) | 5 mg/mL | 0.2 mg/mL | 2 mg/mL | Not available in Europe |
Adding Gestagen options | Not needed to initiate puberty | Add once bleeding occurs or after 2 years | ||
Medroxyprogesterone acetate (e.g. Provera) | 10 mg/tablet | Give with E2, or alone for 10 days/cycle | ||
Dydrogesterone (Duphaston) | 10 mg/tablet | Give with E2, or alone for 10 days/cycle | ||
Micronised progesterone (e.g. Prometrium, Utrogestan, Progesterone Besins) | 100 and 200 mg /tablet | Give with E2, or alone for 10 days/cycle | Utrogestan: before going to bed, lactose-free, indication: galactosemia | |
Progesterone (e.g. Luttagen, Luteina) | ||||
Jaydess, Kyleena, Mirena | Intrauterine device | Give with E2 | ||
Combined E2/Gestagen sequential patch | Do not use to initiate puberty | |||
Climara Pro | E20.045 mg/levonorgestrel 0.015 mg/24 h | 1 patch weekly | ||
Combipatch | E20.045 mg/norethidrone 0.14 or 0.25 mg/24 h | 1 patch weekly | ||
Evo-Sequi | E250 µg/norethisterone acetate 170 µg/24 h | 1 patch twice weekly | ||
Systen Sequi | ||||
Combined E2/Gestagen sequential pills | Do not use to initiate puberty | |||
Trisequens | E22 mg/norethisterone acetate 1 mg | 1 pill/day | ||
Divina plus | Oestradiol valerate 2 mg/medroxyprogesterone acetate 10 mg | 1 pill/day | ||
Femoston 1/10 or 2/10 | Tablet 1–14: 1–2 mg E2; Tablet 15–28: 1–2 mgE2+ 10 mg dydrogesterone |
1 tablet/day | ||
Femoston Continu | All tablets: 1 mg E2/5 mg dydrogesterone | 1 tablet/day | ||
Oral contraceptive pills | Ethinyl estradiol and progestins | Do not use it to initiate puberty | ||
Loestrin (norethindrone) | Less progestational, less androgenic, low estrogenic | |||
Lo-ovral (norgestrel) | More progestational, intermediate androgenic, low estrogenic | |||
Orthotricylcen (norgestimate) | Less androgenic but progestational and more estrogenic |
*Detailed comments are in the text; **To avoid cutting (in daily practice, we cut the patches and inform our patients how to cut them; however, there is no manual in the product’s label); ***The preparation with the appropriate dose should be prepared by a pharmacist.